title: Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.
authors.affiliation: Department of Cardiovascular Surgery, Stanford University School of Medicine, California 94305-5247.
authors.forename: B
authors.initials: B
authors.lastname: Zheng
authors.forename: R
authors.initials: R
authors.lastname: Shorthouse
authors.forename: M A
authors.initials: MA
authors.lastname: Masek
authors.forename: G
authors.initials: G
authors.lastname: Berry
authors.forename: M E
authors.initials: ME
authors.lastname: Billingham
authors.forename: R E
authors.initials: RE
authors.lastname: Morris
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D008213:Lymphocyte Activation / Q000187:drug effects; D008221:Lymphoid Tissue / Q000187:drug effects / Q000276:immunology*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D011090:Polyenes / Q000494:pharmacology*; D051381:Rats; D012016:Reference Values; D020123:Sirolimus; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D016559:Tacrolimus; D013950:Thymus Gland / Q000187:drug effects / Q000276:immunology
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus; D016559:Tacrolimus